← Back to Clinical Trials
Recruiting NCT06446362

NCT06446362 Client-Centered Breastfeeding Support: Effects on Primipara Mothers in a Randomized Trial Breastfeeding Self-Efficacy, Attitudes, and Problems in Primiparous Mothers: A Randomized Controlled Trial

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06446362
Status Recruiting
Phase
Sponsor Pamukkale University
Condition Breastfeeding Self-Efficacy Attitude to Health Postpartum Period Primiparity
Study Type INTERVENTIONAL
Enrollment 45 participants
Start Date 2024-12-01
Primary Completion 2026-09-01

Eligibility & Interventions

Sex Female only
Min Age 15 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
IMCHB-Based Breastfeeding Support ProgramStandard Breastfeeding Education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 45 participants in total. It began in 2024-12-01 with a primary completion date of 2026-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Study Description The goal of this randomized controlled trial is to examine the effects of a client health behavior interaction model-based breastfeeding support program on breastfeeding self-efficacy, attitudes, and problems in primipara mothers. The main questions it aims to answer are: 1. How does the program influence mothers' self-efficacy in breastfeeding? 2. What impact does the program have on mothers' attitudes towards breastfeeding and the problems they encounter? Participants will: 1. Receive breastfeeding support through an interactive health behavior model. 2. Participate in assessments of their breastfeeding self-efficacy and attitudes at designated intervals throughout the study duration. There is a comparison group: 1\. Researchers will compare the intervention group (mothers receiving the structured program) to a control group (mothers receiving standard care) to see if there is a significant difference in outcomes related to breastfeeding self-efficacy, attitudes, and encountered problems.

Eligibility Criteria

Inclusion Criteria: * Primiparous mothers * Gestational age between 32-40 weeks * Ability to communicate effectively * Ownership of a smartphone * Minimum education level: primary school graduate Exclusion Criteria: * Infants with health issues * Mothers with medical or pregnancy-related complications that hinder breastfeeding (e.g., heart disease, cancer, nephritis, active or untreated tuberculosis, HIV/AIDS, active herpes lesions on the breast, severe malnutrition) * Participants undergoing infertility treatment with IVF

Frequently Asked Questions

Who can join the NCT06446362 clinical trial?

This trial is open to female participants only, aged 15 Years or older, up to 35 Years, studying Breastfeeding Self-Efficacy Attitude to Health Postpartum Period Primiparity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06446362 currently recruiting?

Yes, NCT06446362 is actively recruiting participants. Visit ClinicalTrials.gov or contact Pamukkale University to inquire about joining.

Where is the NCT06446362 trial being conducted?

This trial is being conducted at Denizli, Turkey (Türkiye).

Who is sponsoring the NCT06446362 clinical trial?

NCT06446362 is sponsored by Pamukkale University. The trial plans to enroll 45 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology